From April 1, 2024 to April 9, 2024, the company has repurchased 285,400 shares, representing 0.06% for CNY 15.24 million. With this, the company has completed the repurchase of 1,781,400 shares, representing 0.38% for CNY 99.99 million under the buyback announced on January 20, 2024.
Guangzhou Kingmed Diagnostics Group Co., Ltd.
Equities
603882
CNE100002VW1
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
40.3 CNY | +5.77% | -10.14% | -35.59% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.59% | 2.61B | |
-16.55% | 8.43B | |
+40.93% | 3.62B | |
-7.88% | 2.48B | |
-7.96% | 2.34B | |
-5.93% | 1.94B | |
-18.96% | 1.56B | |
-38.35% | 1.26B | |
+6.91% | 1.1B | |
-10.43% | 1.03B |
- Stock Market
- Equities
- 603882 Stock
- News Guangzhou Kingmed Diagnostics Group Co., Ltd.
- Tranche Update on Guangzhou Kingmed Diagnostics Group Co., Ltd.'s Equity Buyback Plan announced on January 20, 2024.